SAT-243-Ledipasvir/sofosbuvir is highly effective and safe in patients with chronic hepatitis B virus and hepatitis C virus coinfection: Final study results

Autor:	Gregory Camus, You-Chun Hsu, Fangqiu Zhang, Chun-Jen Liu, Rong-Nan Chien, Wan-Long Chuang, Chi-Jen Chu, Tsung-Hui Hu, Deyuan Jiang, Anuj Gaggar, Chi-Yi Chen, I-Shyan Sheen, Kuo-Chih Tseng, Vithika Suri, Benedetta Massetto, Horng-Yuan Wang, Pei-Jer Chen, Jyh-Jou Chen, Cheng Yuan Peng, Ting-Tsung Chang, Gin-Ho Lo
Rok vydání:	2019
Předmět:	Hepatology Chronic hepatitis business.industry Hepatitis C virus Coinfection LEDIPASVIR/SOFOSBUVIR Medicine In patient business medicine.disease_cause medicine.disease Virology Virus
Zdroj:	Journal of Hepatology. 70:e739
ISSN:	0168-8278
DOI:	10.1016/s0618-8278(19)31476-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2e53054796279282da68d5d116b63f3a https://doi.org/10.1016/s0618-8278(19)31476-8 Zobrazit plný text záznamu Full Text from ScienceDirect